TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35495374

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastrojejunostomy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Billroth II with Braun anastomosis
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 84
Study: 33923532

Group type: EXPERIMENTAL
Intervention: Probiotic mixture containing Bifidobacterium animalis subsp. Lactis BB12 and Enterococcus faecium L3, administered daily for 3 months before allergen exposure
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 36617189

Group type: EXPERIMENTAL
Intervention: Chronic shoulder pain group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 39
Study: 32507490

Group type: EXPERIMENTAL
Intervention: Coadministered lidocaine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intranasal lidocaine administration
Number of subjects: 51
Study: 35134951

Group type: EXPERIMENTAL
Intervention: Rotarix
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 33989286

Group type: EXPERIMENTAL
Intervention: Music therapy (twice a week from the 21st day of life till discharge)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 65
Study: 32452336

Group type: EXPERIMENTAL
Intervention: Group PM+ (five sessions of 2.5-3 hours each)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) - brief psycho-education and referral options to primary care services
Number of subjects: 121
Study: 35240260

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 24 weeks, 3 times per week
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study: 33291535

Group type: EXPERIMENTAL
Intervention: CHO_M (CHO–electrolyte solution + MBI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (non‐carbohydrate solution + travelling introduction audio)
Number of subjects: 14

Group type: COMPARATOR
Intervention: CHO (CHO–electrolyte solution + travelling introduction audio)
Number of subjects: 14
Study: 33823373

Group type: EXPERIMENTAL
Intervention: Compression force <82.5 N for CC
Number of subjects: 25286

Group type: EXPERIMENTAL
Intervention: Compression force <92.0 N for MLO
Number of subjects: 25286

Group type: EXPERIMENTAL
Intervention: Pressure <7.2 kPa for MLO
Number of subjects: 25286

Group type: EXPERIMENTAL
Intervention: Continuous exposures of force and pressure
Number of subjects: 25286
Study: 35242209

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 148

Group type: COMPARATOR
Intervention: Clopidothiol
Number of subjects: 148
Study: 33626250

Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine (first dose, days 14-20)
Number of subjects: 596618

Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine (second dose, 7 or more days after)
Number of subjects: 596618
Study: 32819929

Group type: EXPERIMENTAL
Intervention: One dose of tranexamic acid (TXA) 1g, intravenous injection 3 hours postsurgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three doses of tranexamic acid (TXA) 1g, intravenous injection at 3, 6, and 12 hours postsurgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study: 35123456

Group type: EXPERIMENTAL
Intervention: 10‐m Walk Test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Figure‐of‐8 Walk Test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 360‐degree Turn Test
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: modified Four Square Step Test
Number of subjects: 38
Study: 33972648

Group type: EXPERIMENTAL
Intervention: Herbicide aminopyralid + fluroxypir associated with lecithin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Herbicide without adjuvants
Number of subjects: 6
Study: 32229447

Group type: EXPERIMENTAL
Intervention: Development Group (DG, n=332)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Validation Group (VG, n=166)
Number of subjects: 498
Study: 35223109

Group type: EXPERIMENTAL
Intervention: Grooved lithotripsy stent
Number of subjects: 96

Group type: COMPARATOR
Intervention: Smooth ureteric stent
Number of subjects: 96
Study: 35195553

Group type: EXPERIMENTAL
Intervention: Prehabilitation (preoperative marking and preoperative education with introduction of the patient to the stoma appliance preoperatively and postoperative education)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Prehabilitation (temporary stoma patients)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control groups A and B (preoperative stoma marking, postoperative education; preoperative marking and preoperative and postoperative education)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control groups (permanent stoma patients)
Number of subjects: 240
Study: 34103095

Group type: EXPERIMENTAL
Intervention: Trans-nasal evaporative cooling during CPR
Number of subjects: 851

Group type: COMPARATOR
Intervention: Control group (no cooling)
Number of subjects: 851
Study: 32006613

Group type: EXPERIMENTAL
Intervention: Interactive advance care planning intervention
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control (symptom management education)
Number of subjects: 460
Study: 616084119

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Femto LASIK
Number of subjects: 20
Study: 32491923

Group type: EXPERIMENTAL
Intervention: Rectal 200 mcg misoprostol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rectal 20 mg hyoscine‐n‐butyl bromide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 90
Study: 35201305

Group type: EXPERIMENTAL
Intervention: Enhanced content
Number of subjects: 7153

Group type: COMPARATOR
Intervention: Standard content
Number of subjects: 7153

Group type: EXPERIMENTAL
Intervention: Enhanced support
Number of subjects: 7153

Group type: COMPARATOR
Intervention: Standard support
Number of subjects: 7153

Group type: EXPERIMENTAL
Intervention: Enhanced content (hematological)
Number of subjects: 7153

Group type: COMPARATOR
Intervention: Standard content (hematological)
Number of subjects: 7153

Group type: EXPERIMENTAL
Intervention: Enhanced support (hematological)
Number of subjects: 7153

Group type: COMPARATOR
Intervention: Standard support (hematological)
Number of subjects: 7153
Study: 32570480

Group type: EXPERIMENTAL
Intervention: Serious game (DoBrain)
Number of subjects: 119

Group type: COMPARATOR
Intervention: NPTs
Number of subjects: 119
Study: 36235870

Group type: EXPERIMENTAL
Intervention: 8-week multi-strategy behavioral intervention including vegetable provisioning and online menu architecture
Number of subjects: 4302

Group type: EXPERIMENTAL
Intervention: 8-week multi-strategy behavioral intervention
Number of subjects: 4302

Group type: COMPARATOR
Intervention: Control group (regular canteen menu)
Number of subjects: 4302
Study: 35586638

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5% Adrenaline
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ropivacaine 0.5%
Number of subjects: 38
Study: 32056820

Group type: EXPERIMENTAL
Intervention: 30-minute music therapy during colonoscopy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine nursing care (control group)
Number of subjects: 112
Study: 35617767

Group type: EXPERIMENTAL
Intervention: Purple packaging
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Natural leaf descriptor
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Grey packs with natural leaf descriptor
Number of subjects: 1063
Study: 32933124

Group type: EXPERIMENTAL
Intervention: High-intensity cold air exercise at 0 C
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-intensity cold air exercise at -20 C
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Post-exertion respiratory function recovery and reported symptoms
Number of subjects: 18
Study: 35120199

Group type: EXPERIMENTAL
Intervention: Canagliflozin (two doses)
Number of subjects: 4327

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4327
Study: 32343445

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention resulting in 10% weight loss
Number of subjects: 125

Group type: COMPARATOR
Intervention: Diet-only intervention
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Diet combined with exercise intervention
Number of subjects: 125
Study: 34410487

Group type: EXPERIMENTAL
Intervention: Bilateral triple osteotomies + Septoplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bilateral triple osteotomies + Spreader grafts + Septoplasty
Number of subjects: 40
Study: 34261527

Group type: EXPERIMENTAL
Intervention: PolyPrime intervention (online video and patient recall process)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 12
Study: 35262569

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on day 1 and 400 mg from day 2 to day 7
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35381848

Group type: EXPERIMENTAL
Intervention: 20 mL rapeseed oil per day (RO)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 20 mL sunflower oil per day (SO)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Habitual diet (CON)
Number of subjects: 84
Study: 33010974

Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU per week for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34812074

Group type: EXPERIMENTAL
Intervention: PICC
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (peripheral venous access)
Number of subjects: 80
Study: 33059911

Group type: EXPERIMENTAL
Intervention: 3 g PNO‐FFA (delivered in delayed-release capsules)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 6 g PNO‐FFA (delivered in delayed-release capsules)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 3 g unhydrolyzed pine nut oil (PNO‐TG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No oil
Number of subjects: 18
Study: 32127178

Group type: EXPERIMENTAL
Intervention: Nonopioid-based analgesia (acetaminophen and ibuprofen)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Opioid-based analgesia
Number of subjects: 95
Study: 34756698

Group type: EXPERIMENTAL
Intervention: Manchester applicator
Number of subjects: 30

Group type: COMPARATOR
Intervention: FSD applicator
Number of subjects: 30
Study: 33131164

Group type: COMPARATOR
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1 g/day)
Number of subjects: 197
Study: 34109697

Group type: EXPERIMENTAL
Intervention: 10‐mg ulipristal acetate (UPA) once daily for three 12‐week courses
Number of subjects: 155
Study: 32681739

Group type: EXPERIMENTAL
Intervention: Decitabine 10 mg/m2 daily for 10 days plus dasatinib 100 mg daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Decitabine 20 mg/m2 daily for 10 days plus dasatinib 100 mg daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Decitabine 10 mg/m2 or 20 mg/m2 daily for 10 days plus dasatinib 140 mg daily (target dose)
Number of subjects: 30
Study: 35699737

Group type: EXPERIMENTAL
Intervention: Conservative Sp o2 target of 88-92%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liberal Sp o2 target of more than 94%
Number of subjects: 0
Study: 34309124

Group type: EXPERIMENTAL
Intervention: Newborn exome sequencing trial participation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control arm of the trial
Number of subjects: 82
Study: 32450857

Group type: EXPERIMENTAL
Intervention: Mail group (postal mail outreach)
Number of subjects: 29145

Group type: COMPARATOR
Intervention: Email group (email outreach)
Number of subjects: 29145

Group type: EXPERIMENTAL
Intervention: Registered members
Number of subjects: 29145
Study: 35879701

Group type: EXPERIMENTAL
Intervention: NP-led care
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 248
Study: 32628030

Group type: EXPERIMENTAL
Intervention: Personal financial incentives
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Charity financial incentives
Number of subjects: 450

Group type: COMPARATOR
Intervention: No-incentive control group
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Choice financial incentives
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Loved one financial incentives
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Post-incentivized period
Number of subjects: 450
Study: 32741619

Group type: EXPERIMENTAL
Intervention: Regular Smarter Pregnancy program (intervention group)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Light Smarter Pregnancy program (control group)
Number of subjects: 626
Study: 35276064

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine plus amodiaquine
Number of subjects: 310

Group type: COMPARATOR
Intervention: Artemether-lumefantrine alone
Number of subjects: 310
Study: 33503302

Group type: EXPERIMENTAL
Intervention: Triple-component single-pill combination (olmesartan/amlodipine/hydrochlorothiazide 20/5/12.5 mg)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Equivalent two-pill regimen (olmesartan/hydrochlorothiazide 20/12.5 mg + amlodipine 5 mg)
Number of subjects: 145
Study: 32383634

Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soft ankle orthosis
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Semirigid ankle orthosis
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 60
Study: 34733500

Group type: EXPERIMENTAL
Intervention: Nutritionally complete meal replacement plan (MRP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 83

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 83
Study: 33779417

Group type: EXPERIMENTAL
Intervention: Three standardized educative phone calls
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130
Study: 36222618

Group type: EXPERIMENTAL
Intervention: 1 gram of Tranexamic Acid (TXA) after induction
Number of subjects: 110

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 110
Study: 34103028

Group type: EXPERIMENTAL
Intervention: Proper sitting postures (42%)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Backpack carrying behaviors (33%)
Number of subjects: 673
Study: 33272946

Group type: EXPERIMENTAL
Intervention: 0.4 mg folic acid
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: 2.8 mg folic acid
Number of subjects: 331

Group type: COMPARATOR
Intervention: 0 mg folic acid
Number of subjects: 331
Study: 34718943

Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation (tDCS) for 20 min at 2 mA
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cathodal cerebellar transcranial direct current stimulation (tDCS) for 20 min at 2 mA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham cerebellar transcranial direct current stimulation (tDCS)
Number of subjects: 20
Study: 34962559

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (120,000 IU of cholecalciferol monthly)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 149
Study: 34811502

Group type: EXPERIMENTAL
Intervention: Baseline circulating tumour DNA (ctDNA) variant allele fraction (VAF)
Number of subjects: 135
Study: 33725270

Group type: EXPERIMENTAL
Intervention: Nonmydriatic ultra‐wide‐field scanning laser ophthalmoscope (SLO) (Optos Daytona)
Number of subjects: 101
Study: 32037556

Group type: EXPERIMENTAL
Intervention: Web-based survey assessing willingness to donate tissues for regenerative therapy
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Increased familiarity with regenerative medicine through a brief paragraph of information
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Support for nonprofit groups in research and development
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Factors influencing donor willingness
Number of subjects: 1118

Group type: EXPERIMENTAL
Intervention: Willingness to donate blood
Number of subjects: 1118
Study: 34482306

Group type: EXPERIMENTAL
Intervention: Customized sound therapy with tinnitus sound matching (group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Customized sound therapy without tinnitus sound matching (group B)
Number of subjects: 100
Study: 32001493

Group type: EXPERIMENTAL
Intervention: Exercise intervention (physiotherapist-led aerobic and resistance exercise including behaviour change techniques)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34610129

Group type: EXPERIMENTAL
Intervention: Whole Milk (WM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Skim Milk (SM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Almond Beverage (AB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Phase 1 to Phase 2 (Diet Intervention)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Phase 2 to Phase 3 (Intervention Diet + PA)
Number of subjects: 22
Study: 32045406

Group type: EXPERIMENTAL
Intervention: Prolotherapy (PrT) injections
Number of subjects: 41

Group type: COMPARATOR
Intervention: Exercise (control group)
Number of subjects: 41
Study: 36350379

Group type: EXPERIMENTAL
Intervention: e‐enabled lifestyle intervention (Women's Wellness after Cancer Program)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 351
Study: 34880957

Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (TSN)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 100
Study: 32458107

Group type: EXPERIMENTAL
Intervention: e-APA (web-based adapted physical activity program)
Number of subjects: 63

Group type: COMPARATOR
Intervention: e-HE (health education program)
Number of subjects: 63
Study: 32558178

Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Thulium laser transurethral vaporesection of the prostate (ThuVARP)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 410

Group type: COMPARATOR
Intervention: ThuVARP
Number of subjects: 410
Study: 35782413

Group type: EXPERIMENTAL
Intervention: Mindfulness training intervention (2 online introductory group sessions followed by 8 weeks of Mindfulness practice)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mindfulness training intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 32021173

Group type: EXPERIMENTAL
Intervention: NSB drug capsules along with the standard of care treatment (Arm B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care treatment (Arm A)
Number of subjects: 0
Study: 35986934

Group type: EXPERIMENTAL
Intervention: Home bleaching with 16% carbamide peroxide (CP) and restriction of colored foods without red wine mouthwash
Number of subjects: 45

Group type: COMPARATOR
Intervention: Home bleaching with 16% carbamide peroxide (CP) with colored foods and red wine mouthwash
Number of subjects: 45

Group type: COMPARATOR
Intervention: Home bleaching with 16% carbamide peroxide (CP) with colored foods without red wine mouthwash
Number of subjects: 45
Study: 34090214

Group type: EXPERIMENTAL
Intervention: Maternal education concerning nutrition, hygiene, and child stimulation for 6 months.
Number of subjects: 511

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 511
Study: 35484744

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: miR-106a nanoparticles (NPs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) and miR-106a nanoparticles (NPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ischemic reperfusion (IR) set
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control set
Number of subjects: 0
Study: 35092666

Group type: COMPARATOR
Intervention: 3LP repair alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: 3VCP
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5VCP
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 7VCP
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5VCP and 7VCP
Number of subjects: 24
Study: 32899089

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham laser (control)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 35
Study: 36251378

Group type: EXPERIMENTAL
Intervention: Individualized behavioral intervention to reduce daily sedentary behavior by 1 hour
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Individualized behavioral intervention
Number of subjects: 64
Study: 33201262

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35789164

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol (0.005%) cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.1% adapalene gel
Number of subjects: 40
Study: 32826000

Group type: EXPERIMENTAL
Intervention: Biomechanical Taping
Number of subjects: 68

Group type: COMPARATOR
Intervention: Kinesio Taping
Number of subjects: 68
Study: 33973806

Group type: EXPERIMENTAL
Intervention: Ferulic acid (200 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34315990

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Nicametate
Number of subjects: 466
Study: 32295092

Group type: EXPERIMENTAL
Intervention: 4.5 g of fructooligosaccharides + 2 g of maltodextrin (FOS group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 2 g of maltodextrin (placebo group)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: FOS supplementation
Number of subjects: 53
Study: 36446689

Group type: EXPERIMENTAL
Intervention: Bilateral TAPB
Number of subjects: 70

Group type: COMPARATOR
Intervention: CEB
Number of subjects: 70
Study: 33574076

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 32316899

Group type: EXPERIMENTAL
Intervention: Proctosoll Allevia® with controlled diet
Number of subjects: 45

Group type: COMPARATOR
Intervention: Controlled diet only
Number of subjects: 45